Success Story: Securing an NIW Approval for an Associate Director in Health Economics and Outcomes Research
Client’s Testimonial:
"I had a very positive experience with Chen Immigration. Their team was professional, efficient, and highly responsive throughout my I-140 process. They provided clear guidance at every step and offered valuable suggestions to strengthen my petition. The entire process felt well-organized and smooth. Thanks to their support, my I-140 was approved 8 working days after upgrading to PP without RFE. I highly recommend Chen Immigration to anyone applying for EB2-NIW or EB1.”
On March 11th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Director in the Field of Health Economics and Outcomes Research (Approval Notice).
General Field: Health Economics and Outcomes Research
Position at the Time of Case Filing: Associate Director
Country of Origin: Taiwan
Country of Residence at the Time of Filing: Ireland
Approval Notice Date: March 11th, 2026
Processing Time: 20 months, 5 days (Premium Processing Upgrade Requested)
Case Summary:
With an M.S. in health economics and decision modeling, the petitioner has built her work around improving how healthcare systems evaluate new treatments and technologies. Her research centers on analyzing the clinical and economic value of emerging health interventions so that decision-makers can make better-informed choices about funding, access, and patient care.
Her work spans pharmaceuticals, innovative medical devices, and broader policy measures, all with the aim of strengthening healthcare decision-making, improving the use of limited resources, and expanding access to effective care. At a time when the United States continues to face serious challenges involving treatment costs and healthcare spending, this type of evidence-based analysis carries clear national importance.
Demonstrating Influence Through a Focused Research Record
In preparing this NIW case, North America Immigration Law Group (Chen Immigration Law Associates) took a focused approach to showing the petitioner’s impact. Rather than depending on a large publication count, we emphasized the strength and reach of a more concentrated research record.
Her work included 2 peer-reviewed journal articles, including 1 first-authored publication, as well as 5 abstracts, 3 of them first-authored. Although modest in number, this body of work had already attracted substantial independent attention, reflected in 129 citations from other researchers. We also highlighted her peer review service, which included at least 2 completed reviews for respected journals, as further evidence that her expertise had been recognized within the field.
Expert Support Highlighting Policy Relevance
An important part of the NIW presentation was showing how her research informs real healthcare policy decisions. To do that, we included testimony from independent experts who explained the practical value of her analyses. One expert, discussing her work on oncology funding decisions, stated:
“Her findings revealed that utilizing immature data in health technology assessment can lead to incorrect estimates of survival benefit and cost-effectiveness, resulting in inappropriate funding decisions, emphasizing the importance of revising decisions when new data become available.”
This kind of expert support helped clarify that her contributions extend beyond academic study. Her research provides decision-makers with tools to evaluate medical interventions more accurately and to avoid costly or ineffective funding outcomes.
We congratulate our client on her NIW approval and look forward to her continued contributions to more effective and equitable healthcare decision-making.